Back to Directory
Last Updated: 05/06/2026

Metrion Biosciences

Cambridge
Founded 2015
Specialist CRO for ion channel screening and cardiac safety assessment

Metrion Biosciences is a contract research organisation specialising in preclinical ion channel biology, cardiac safety screening, and neuroscience drug discovery services.

Founded in 2015 as a spin-out from Xention Limited, Metrion provides automated and manual patch clamp electrophysiology, GLP-compliant hERG testing, CiPA cardiac ion channel panel screening, and translational neuroscience assays.

It serves pharmaceutical and biotechnology companies globally on a fee-for-service or collaborative basis from its laboratories at Granta Park, Cambridge.

Company Notes

Previously Known As
Xention